US 8658787
Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
granted A61KA61K31/732A61K31/736
Quick answer
US patent 8658787 (Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease) held by GALECTIN THERAPEUTICS, INC. expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GALECTIN THERAPEUTICS, INC.
- Grant date
- Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 44
- CPC classes
- A61K, A61K31/732, A61K31/736, A61K45/06, A61P